Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer

被引：9
|
作者：
Tas, F [1 ]
Aykan, F [1 ]
Aydiner, A [1 ]
Yasasever, V [1 ]
Topuz, E [1 ]
机构：
[1] Istanbul Univ, Inst Oncol, Div Med Oncol, TR-34390 Istanbul, Turkey
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2001年 / 24卷 / 02期
关键词：
gastric cancer; recurrence; CEA; CA; 19-9;
D O I：
10.1097/00000421-200104000-00010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In 35 patients with recurrent gastric cancer who had undergone curative gastrectomy, serum carcinoembryonic antigen (CEA) and CA 19-9 (carbohydrate antigen) rumor marker levels were investigated. At least one tumor marker was elevated in 24 (68.6%) patients. The levels of serum CA 19-9 and CEA markers were increased in 20 (57.1%,) and 12(34.3%) patients, respectively. This difference was not statistically significant. However, it may be important in terms of clinical practice.
引用
收藏
页码：148 / 149
页数：2
相关论文
共 50 条
  • [1] CEA and CA 19-9 are Still Valuable Markers for the Prognosis of Colorectal and Gastric Cancer Patients
    Sisik, Abdullah
    Kaya, Mustafa
    Bas, Gurhan
    Basak, Fatih
    Alimoglu, Orhan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (07) : 4289 - 4294
  • [2] Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer
    Jo, Jae-Cheol
    Ryu, Min-Hee
    Koo, Dong-Hoe
    Ryoo, Baek-Yeol
    Kim, Hwa Jung
    Kim, Tae Won
    Choi, Kee Don
    Lee, Gin Hyug
    Jung, Hwoon-Yong
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kim, Jin-Ho
    Kang, Yoon-Koo
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 (04) : 324 - 330
  • [3] Combined use of CEA, CA 19-9 and AFP for the preoperative prediction of stage IV gastric cancer
    Look, M
    Teh, CH
    Yeong, WS
    Gn, C
    Low, CH
    GI CANCER, 1998, 2 (04): : 277 - 283
  • [4] Levels of tumor markers CEA/CA 19-9 in serum and peritoneal lavage predict postoperative recurrence in patients with pancreatic cancer
    Hata, Tatsuo
    Chiba, Kazuharu
    Mizuma, Masamichi
    Masuda, Kunihiro
    Ohtsuka, Hideo
    Nakagawa, Kei
    Morikawa, Takanori
    Hayashi, Hiroki
    Motoi, Fuyuhiko
    Unno, Michiaki
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2022, 6 (06): : 862 - 872
  • [5] Assessment of prognostic values of serum CEA and CA 19-9 concentration in patients with colorectal cancer
    Tuteska, J.
    Arapceska, M.
    Stojkovski, V.
    Gligurovska, J.
    CLINICA CHIMICA ACTA, 2019, 493 : S121 - S121
  • [6] Correlation Analysis of Baseline Serum CA 19-9, CEA, and CA 125 in Patients With Advanced Pancreatic Cancer
    Deng, G.
    Yan, H.
    Guo, Z.
    Dai, G.
    PANCREAS, 2020, 49 (10) : 1406 - 1406
  • [7] Serum CA 19-9, SLX, STN and CEA levels of the peripheral and the draining venous blood in gastric cancer
    Imada, T
    Rino, Y
    Takahashi, M
    Hatori, S
    Shiozawa, M
    Amano, T
    Kondo, J
    HEPATO-GASTROENTEROLOGY, 1999, 46 (27) : 2086 - 2090
  • [8] The prognostic significance of gastric juice CA 19-9 and CEA levels in gastric carcinoma patients
    Duraker, N
    Çelik, AN
    Gençler, N
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (08): : 844 - 849
  • [9] The Relationships Between Perioperative CEA, CA 19-9, and CA 72-4 and Recurrence in Gastric Cancer Patients After Curative Radical Gastrectomy
    Kim, Dae Hoon
    Oh, Seung Jong
    Oh, Cheong Ah
    Choi, Min Gew
    Noh, Jae Hyung
    Sohn, Tae Sung
    Bae, Jae Moon
    Kim, Sung
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (06) : 585 - 591
  • [10] Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer
    Moriyama, Jin
    Oshima, Yoko
    Nanami, Tatsuki
    Suzuki, Takashi
    Yajima, Satoshi
    Shiratori, Fumiaki
    Funahashi, Kimihiko
    Shimada, Hideaki
    SURGERY TODAY, 2021, 51 (10) : 1638 - 1648
12345